ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (36)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Bredow, C.
Right arrow Articles by Griese, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Bredow, C.
Right arrow Articles by Griese, M.
Eur Respir J 2001; 17:716-722
Copyright ©ERS Journals Ltd 2001


Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis

C. von Bredow1, P. Birrer2 and M. Griese1

1 Children's Clinic of Ludwig-Maximilians-University, Munich, Germany. 2 Children's Clinic, Inselspital, University of Bern, Switzerland

CORRESPONDENCE: M. Griese, Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital, Ludwig-Maximilians University, Pettenkoferstrasse 8a, Munich, Germany, D-80336. Fax: 49 8951603477

Keywords: bronchoalveolar lavage, cystic fibrosis, proteome, surfactant protein A

Received: August 30, 2000
Accepted December 8, 2000

This project was supported by a grant from the Wilhelm Sander Stiftung (Gr 93.002.1/2).

Inflammation and proteolytic processes play an important role in the progression of cystic fibrosis (CF) lung disease. The goal of this study was to describe bronchoalveolar lavage fluid (BALF) protein pattern of CF patients in comparison to controls and to assess if there is proteolytic degradation of surfactant protein A (SP-A), an important innate host defence component of the lungs.

BALFs from 17 clinically stable CF patients and from eight healthy children were separated by two-dimensional gel electrophoresis. Silver staining was used to show BALF proteins and Western blotting to detect SP-A isoforms.

In CF, BALF proteins of a low molecular weight ≤20 kD were more abundant than in controls. Various proteins were seen in CF which were not present in controls and vice versa. Degradation of SP-A was present in 15 of 17 CF BALFs but in none of the controls, in contrast polymeric isoforms were seen in all controls and in four of 17 CF patients.

Proteolytic damage to surfactant protein A and significant changes of normal bronchoalveolar lavage fluid proteins occur in lungs of cystic fibrosis patients. Identification of altered bronchoalveolar lavage fluid proteins may give new insights into pathogenic mechanisms and provide new targets for therapy.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. R. S. Tagaram, G. Wang, T. M. Umstead, A. N. Mikerov, N. J. Thomas, G. R. Graff, J. C. Hess, M. J. Thomassen, M. S. Kavuru, D. S. Phelps, et al.
Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health
Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1052 - L1063.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
V. Starosta, E. Rietschel, K. Paul, U. Baumann, and M. Griese
Oxidative Changes of Bronchoalveolar Proteins in Cystic Fibrosis.
Chest, February 1, 2006; 129(2): 431 - 437.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. P. Carroll, C. M. Greene, C. C. Taggart, A. G. Bowie, S. J. O'Neill, and N. G. McElvaney
Viral Inhibition of IL-1- and Neutrophil Elastase-Induced Inflammatory Responses in Bronchial Epithelial Cells
J. Immunol., December 1, 2005; 175(11): 7594 - 7601.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. J. Sloane, R. A. Lindner, S. S. Prasad, L. T. Sebastian, S. K. Pedersen, M. Robinson, P. T. Bye, D. W. Nielson, and J. L. Harry
Proteomic Analysis of Sputum from Adults and Children with Cystic Fibrosis and from Control Subjects
Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1416 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Griese, R. Essl, R. Schmidt, E. Rietschel, F. Ratjen, M. Ballmann, K. Paul, and for the BEAT Study Group
Pulmonary Surfactant, Lung Function, and Endobronchial Inflammation in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., November 1, 2004; 170(9): 1000 - 1005.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Hirsch, K. C. Hansen, A. L. Burlingame, and M. A. Matthay
Proteomics: current techniques and potential applications to lung disease
Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L1 - L23.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. P. Bowler, B. Duda, E. D. Chan, J. J. Enghild, L. B. Ware, M. A. Matthay, and M. W. Duncan
Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1095 - L1104.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
F Rubio, J Cooley, F J Accurso, and E Remold-O'Donnell
Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease
Thorax, April 1, 2004; 59(4): 318 - 323.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. A. Gold, Y. Hoshino, N. Tanaka, W. N. Rom, B. Raju, R. Condos, and M. D. Weiden
Surfactant Protein A Modulates the Inflammatory Response in Macrophages during Tuberculosis
Infect. Immun., February 1, 2004; 72(2): 645 - 650.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
H Clark and K Reid
The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema
Arch. Dis. Child., November 1, 2003; 88(11): 981 - 984.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. L. Noah, P. C. Murphy, J. J. Alink, M. W. Leigh, W. M. Hull, M. T. Stahlman, and J. A. Whitsett
Bronchoalveolar Lavage Fluid Surfactant Protein-A and Surfactant Protein-D Are Inversely Related to Inflammation in Early Cystic Fibrosis
Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 685 - 691.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
F. Sabounchi-Schutt, J. Astrom, U. Hellman, A. Eklund, and J. Grunewald
Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach
Eur. Respir. J., March 1, 2003; 21(3): 414 - 420.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. L. Aitken, K. E. Greene, M. R. Tonelli, J. L. Burns, J. C. Emerson, C. H. Goss, and R. L. Gibson
Analysis of Sequential Aliquots of Hypertonic Saline Solution-Induced Sputum From Clinically Stable Patients With Cystic Fibrosis
Chest, March 1, 2003; 123(3): 792 - 799.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Griese, N. Maderlechner, P. Ahrens, and R. Kitz
Surfactant Proteins A and D in Children with Pulmonary Disease due to Gastroesophageal Reflux
Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1546 - 1550.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. R. Korfhagen
Surfactant Protein A (SP-A)-Mediated Bacterial Clearance . SP-A and Cystic Fibrosis
Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 668 - 672.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.